Baxter Revenue 2006-2019 | BAX

Baxter annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Baxter revenue for the quarter ending September 30, 2019 was $2.851B, a 3.04% increase year-over-year.
  • Baxter revenue for the twelve months ending September 30, 2019 was $11.164B, a 0.94% increase year-over-year.
  • Baxter annual revenue for 2018 was $11.127B, a 5.36% increase from 2017.
  • Baxter annual revenue for 2017 was $10.561B, a 3.92% increase from 2016.
  • Baxter annual revenue for 2016 was $10.163B, a 1.96% increase from 2015.
Baxter Annual Revenue
(Millions of US $)
2018 $11,127
2017 $10,561
2016 $10,163
2015 $9,968
2014 $10,719
2013 $9,413
2012 $13,936
2011 $13,893
2010 $12,843
2009 $12,562
2008 $12,348
2007 $11,263
2006 $10,378
2005 $9,849
Baxter Quarterly Revenue
(Millions of US $)
Q3 2019 $2,851
Q2 2019 $2,840
Q1 2019 $2,632
Q4 2018 $2,841
Q3 2018 $2,767
Q2 2018 $2,842
Q1 2018 $2,677
Q4 2017 $2,774
Q3 2017 $2,707
Q2 2017 $2,605
Q1 2017 $2,475
Q4 2016 $2,645
Q3 2016 $2,558
Q2 2016 $2,585
Q1 2016 $2,375
Q4 2015 $2,603
Q3 2015 $2,487
Q2 2015 $2,475
Q1 2015 $2,403
Q4 2014 $2,789
Q3 2014 $2,709
Q2 2014 $4,154
Q1 2014 $3,848
Q4 2013 $4,322
Q3 2013 $3,710
Q2 2013 $3,669
Q1 2013 $3,448
Q4 2012 $3,499
Q3 2012 $3,477
Q2 2012 $3,572
Q1 2012 $3,388
Q4 2011 $3,594
Q3 2011 $3,479
Q2 2011 $3,536
Q1 2011 $3,284
Q4 2010 $3,498
Q3 2010 $3,224
Q2 2010 $3,194
Q1 2010 $2,927
Q4 2009 $3,470
Q3 2009 $3,145
Q2 2009 $3,123
Q1 2009 $2,824
Q4 2008 $3,131
Q3 2008 $3,151
Q2 2008 $3,189
Q1 2008 $2,877
Q4 2007 $3,009
Q3 2007 $2,750
Q2 2007 $2,829
Q1 2007 $2,675
Q4 2006 $2,763
Q3 2006 $2,557
Q2 2006 $2,649
Q1 2006 $2,409
Q4 2005 $2,491
Q3 2005 $2,398
Q2 2005 $2,577
Q1 2005 $2,383
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $46.512B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $162.145B 22.40
Abbott Laboratories (ABT) United States $160.452B 28.00
Stryker (SYK) United States $80.889B 27.20
Boston Scientific (BSX) United States $60.729B 28.66
EssilorLuxottica Societe Anonyme (ESLOY) France $33.852B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.752B 19.29
Lonza Group Ag (LZAGY) Switzerland $30.666B 0.00
Terumo (TRUMY) Japan $27.814B 34.71
Coloplast (CLPBY) Denmark $27.238B 42.03
ResMed (RMD) United States $23.206B 42.81
Smith & Nephew SNATS (SNN) United Kingdom $21.605B 0.00
Sunny Optical Technology (SNPTF) China $19.732B 0.00
Insulet (PODD) United States $11.870B 564.71
Bio-Rad Laboratories (BIO) United States $11.235B 53.93
Canopy Growth (CGC) Canada $8.566B 0.00
Perrigo (PRGO) Ireland $8.096B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.553B 22.21
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.578B 37.69
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.024B 31.68
ICU Medical (ICUI) United States $3.895B 25.39
Neogen (NEOG) United States $3.688B 61.38
GW Pharmaceuticals (GWPH) United Kingdom $3.580B 0.00
Quidel (QDEL) United States $3.196B 30.33
Agios Pharmaceuticals (AGIO) United States $3.136B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.086B 0.00
National Vision Holdings (EYE) United States $2.814B 63.52
Aurora Cannabis (ACB) Canada $2.255B 0.00
Cardiovascular Systems (CSII) United States $1.860B 0.00
InMode (INMD) Israel $1.591B 0.00
AtriCure (ATRC) United States $1.483B 0.00
Aphria (APHA) $1.455B 0.00
TG Therapeutics (TGTX) United States $1.349B 0.00
VAREX IMAGING (VREX) United States $1.191B 23.81
NanoString Technologies (NSTG) United States $1.058B 0.00
Phibro Animal Health (PAHC) United States $1.042B 19.51
PetIQ (PETQ) United States $0.869B 21.19
Eagle Pharmaceuticals (EGRX) United States $0.793B 30.36
Lantheus Holdings (LNTH) United States $0.739B 18.45
LeMaitre Vascular (LMAT) United States $0.733B 41.20
Quanterix (QTRX) United States $0.721B 0.00
Omeros (OMER) United States $0.682B 0.00
Cerus (CERS) United States $0.629B 0.00
Surmodics (SRDX) United States $0.562B 58.24
MacroGenics (MGNX) United States $0.558B 0.00
OraSure Technologies (OSUR) United States $0.509B 30.52
Organigram Holdings (OGI) Canada $0.472B 0.00
Owens & Minor (OMI) United States $0.420B 15.56
Meridian Bioscience (VIVO) United States $0.412B 14.15
HEXO (HEXO) $0.408B 0.00
Utah Medical Products (UTMD) United States $0.384B 27.84
Zynex (ZYXI) United States $0.341B 38.59
BioLife Solutions (BLFS) United States $0.317B 129.00
Bovie Medical (APYX) United States $0.281B 0.00
Female Health (VERU) United States $0.279B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.270B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Repro-Med Systems (KRMD) United States $0.227B 0.00
United Health Products (UEEC) United States $0.222B 0.00
Viemed Healthcare (VMD) United States $0.217B 22.92
Liberty Health Sciences (LHSIF) Canada $0.184B 0.00
InfuSystems Holdings (INFU) United States $0.171B 863.00
Green Organic Dutchman Holdings (TGODF) Canada $0.169B 0.00
Rockwell Medical (RMTI) United States $0.166B 0.00
Cytosorbents (CTSO) United States $0.152B 0.00
Fonar (FONR) United States $0.134B 9.42
Chimerix (CMRX) United States $0.122B 0.00
MTech Acquisition (KERN) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Surface Oncology (SURF) United States $0.091B 0.00
United-Guardian (UG) United States $0.082B 20.65
MRI Interventions (MRIC) United States $0.079B 0.00
Nephros (NEPH) United States $0.076B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) $0.051B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00